Provided by Tiger Fintech (Singapore) Pte. Ltd.

EyePoint

10.45
-0.0900-0.85%
Post-market: 10.450.00000.00%19:33 EDT
Volume:627.02K
Turnover:6.55M
Market Cap:719.08M
PE:-4.31
High:10.77
Open:10.60
Low:10.26
Close:10.54
Loading ...

EyePoint Pharma’s Earnings Call: Clinical Progress Amid Financial Challenges

TIPRANKS
·
07 Mar

EyePoint Pharmaceuticals Is Maintained at Buy by Chardan Capital

Dow Jones
·
07 Mar

EyePoint Pharmaceuticals Price Target Maintained With a $22.00/Share by HC Wainwright & Co.

Dow Jones
·
06 Mar

EyePoint Pharmaceuticals: Promising Clinical Progress and Strong Financial Position Justify Buy Rating

TIPRANKS
·
06 Mar

Despite Recent Gains, EyePoint Pharmaceuticals Insiders Are Still Down US$32k

Simply Wall St.
·
06 Mar

Q4 2024 EyePoint Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
06 Mar

EyePoint Pharmaceuticals Inc (EYPT) Q4 2024 Earnings Call Highlights: Navigating Challenges ...

GuruFocus.com
·
06 Mar

EyePoint Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
06 Mar

EyePoint Pharmaceuticals (EYPT) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
05 Mar

Scotiabank Sticks to Their Buy Rating for EyePoint Pharmaceuticals (EYPT)

TIPRANKS
·
05 Mar

EyePoint Pharmaceuticals: Q4 Earnings Snapshot

Associated Press Finance
·
05 Mar

EyePoint Pharmaceuticals' $371M Of Cash And Investments On December 31, 2024, Providing Cash Runway Into 2027 Beyond Topline Duravyu Phase 3 Wet AMD Data Expected In 2026

Benzinga
·
05 Mar

EyePoint Pharmaceuticals Q4 2024 GAAP EPS $(0.64) Misses $(0.51) Estimate, Sales $11.59M Beat $11.09M Estimate

Benzinga
·
05 Mar

EyePoint Pharmaceuticals Inc: $371 Mln of Cash and Investments on Dec 31, 2024, Providing Cash Runway Into 2027

THOMSON REUTERS
·
05 Mar

EyePoint Pharmaceuticals Q4 Product Sales USD 774 Thousand

THOMSON REUTERS
·
05 Mar

EyePoint Reports Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Developments

GlobeNewswire
·
05 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
05 Mar

EyePoint Announces Participation at Upcoming Investor Conferences

GlobeNewswire
·
04 Mar

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) May Have Run Too Fast Too Soon With Recent 30% Price Plummet

Simply Wall St.
·
27 Feb

EyePoint to Report Fourth Quarter and Full-Year 2024 Financial Results on March 5, 2025

GlobeNewswire
·
26 Feb